DOCSLIB.ORG

Information for Authors

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Information for Authors Information for Authors The Lancet Respiratory Medicine considers any original research contribution that advocates change in or illuminates clinical practice and informative reviews on any topic connected with respiratory medicine and critical care. Because the journal has an international readership from a wide range of specialties, it is vital that articles should be written clearly and should not assume a level of knowledge above that of, say, a reasonably well-read, junior doctor. One way to find out if your article is understandable to those reading outside their immediate field of interest is to show the manuscript to colleagues in other specialties. If they find it difficult to follow, so will a good proportion of the readership of The Lancet Respiratory Medicine. Wherever possible, figures and good quality photographs (colour or black and white) should be used to supplement and to enhance the text. Further details on the different sections of The Lancet Respiratory Medicine, and how to submit to the journal, are provided below. If you require further clarification, the journal’s editorial staff will be pleased to help (email [email protected]). Manuscripts must be solely the work of the author(s) stated, must not have been previously published elsewhere, and must not be under consideration by another journal. The Lancet journals are signatories of the Recommendations for the Conduct, Recommendations for the Reporting, Editing, and Publication of Scholarly Work in Medical Journals, issued by the International Committee of Medical Conduct, Reporting, Editing, Journal Editors (ICMJE Recommendations), and to the Committee on Publication Ethics (COPE) code of conduct for editors. We and Publication of Scholarly Work in Medical Journals follow COPE’s guidelines. http://www.icmje.org How to submit your paper First submissions to The Lancet Respiratory Medicine sh ould COPE Core Practices Manuscript submission https://publicationethics.org/ include: core-practices Manuscript submission to all Lancet journals is free. Manuscripts 1 Covering letter should be submitted online via the The Lancet Respiratory Medicine’s 2 Manuscript including tables and panels online submission and peer review website (known as EM) at www. 3 Figures editorialmanager.com/thelancetrm 4 Author statement form (see next section) 5 Declaration of interests and source of funding statements • Simply log on to EM and follow the on-screen instructions for all (see next section) submissions 6 In-press papers—one copy of each with acceptance letters • If you have not used EM before, you will need to register first. In 7 Protocols and CONSORT details for randomised controlled EM, the corresponding author is the person who enters the trials (see Articles) manuscript details and uploads the submission files 8 We encourage disclosure of correspondence from other • Inclusion of illustrations (eg, photographs, graphs, diagrams) is a journals and reviewers, if previously submitted, and we prerequisite for many publication types. Submission of original might contact relevant editors of such journals and editable artwork files is encouraged. Digital photography 9 Research in Context panel, for all primary research Articles files should have a resolution of at least 300 dpi and be at least 107 mm wide. Before and after images should be taken with the Covering letter same intensity, direction, and colour of light • You should upload your covering letter at the • In almost all cases, if you have a finished manuscript, you should “Enter Comments” stage of the online submission process submit it, rather than contacting The Lancet Respiratory Medicine • Use the covering letter to explain why your paper should be to enquire whether an unseen manuscript is likely to be accepted. published in The Lancet Respiratory Medicine rather than elsewhere Unless you have been asked by the Editor to submit by email, you • It is helpful to indicate what could shorten your paper—the full should use the online system for all types of submission, paper can be reviewed and a shorter version published; a table or including Correspondence figure, details of a DNA sequence, or further references, for • If you have any technical problems or questions, please contact example, can be published on our website or made available our dedicated customer support: from the authors For the Americas: +1 888 8347287 (09:00 to 17:00 Statements, permissions, and signatures central standard time) Authors and contributors For Asia and Pacific: +81 3 55615032 (09:30 to 17:30 • Designated authors should meet all four criteria for authorship Japan standard time) in the ICMJE Recommendations ICMJE Recommendations For Europe and rest of the world: +44 1865 843577 • All authors, and all contributors (including medical writers and http://www.icmje.org (08:30 to 17:00 GMT) editors), should specify their individual contributions at the end For Chinese-speaking customers: +86 10 85208780 of the text (9:00 to 17:30 China standard time) • We require that more than one author has verified the For Spanish-speaking customers: +34 932 406176 underlying data. The contributors statement should state who (09:00 to 17:00 GMT) those authors are. For French-speaking customers: +33 171 165608 • All authors should confirm that they had full access to all the data (09:00 to 17:00 GMT) in the study and accept responsibility to submit for publication Email: [email protected] • We encourage collaboration and coauthorship with colleagues in the locations where the research is conducted www.thelancet.com August 2021 Information for Authors • The Lancet Group takes a neutral position with respect to territorial to provide the journal with any such agreements in confidence. claims in institutional affiliations • At the end of the text, under a subheading “Declaration of • When choosing coauthors, we ask lead authors to be mindful of interests”, all authors must disclose any financial and personal the benefits of diversity in authorship and to consider inviting relationships with other people or organisations, even if it does not coauthors who reflect diversity in every sense, including (but not directly relate to the submitted work. Examples of financial conflicts limited to) background, career-stage, gender, geography, and race include employment, consultancies, stock ownership, honoraria, • The Lancet Respiratory Medicine will not publish any paper unless paid expert testimony, patents or patent applications, and travel we have the signatures of all authors grants, all within 3 years of beginning the work submitted. If there Author statement form • We suggest you use the author statement form and upload the are no conflicts of interest, authors should state that none exist https://www.thelancet. signed copy with your submission • All authors are required to provide a Conflict of Interest Statement com/for-authors/ • Please include written consent of any cited individual(s) noted in and should complete a standard form, which is available at https:// forms?section=tlrm-author-sig acknowledgments or personal communications www.thelancet.com/for-authors/forms?section=icmje-coi. The • For author groups of more than 30 members, we encourage use form has been modified by the ICMJE following consultation with of a collaborator or study group for any additional authors. For authors and editors. Further information is available in a joint this collaborator or study group, if they wish to be indexed to the ICMJE statement published on July 1, 2010. For more information paper, please provide a separate document with a table of first see Lancet 2009; 374: 1395–96. names and surnames of all members of the group (this is to ensure • For Comments, Personal Views, and Reviews, The Lancet that PubMed and similar databases encode the names correctly). Respiratory Medicine will not publish if an author, within the past 3 years, and with a relevant company or competitor, has Forms and signatures any stocks or shares, equity, a contract of employment, or a For Reviews, Personal Views, Comments, and Correspondence, named position on a company board; or has been asked by any we require you to upload your forms at submission. For original organisation other than The Lancet Respiratory Medicine to research (Articles), we will request these forms after peer review. The write, be named on, or to submit the paper (see Lancet 2004; following signed statements are required: 363: 2–3) ICMJE COI form • Authors’ contributions https://www.thelancet. • Conflicts of interest statements (ICMJE forms) Role of the funding source com/for-authors/ • Statements of role, if any, of medical writer or editor • All sources of funding should be declared as an forms?section=icmje-coi • Acknowledgments—written consent of cited individual acknowledgment at the end of the text Joint ICMJE statement • Personal communications—written consent of cited individual • At the end of the Methods section, under a subheading “Role of https://www.thelancet.com/ • Use of copyright-protected material—signed permission the funding source”, authors must describe the role of the study for-authors/forms?section=icmje- statements from author and publisher sponsor(s), if any, in study design; in the collection, analysis, and statement These statements can be scanned and submitted electronically with interpretation of data; in the writing of the report; and in the your submission. Please note that The Lancet journals will accept decision to submit the paper for publication hand-signed
Load more

Recommended publications
  • Tissue and Cell
    TISSUE AND CELL AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Impact Factor p.1 • Abstracting and Indexing p.1 • Editorial Board p.1 • Guide for Authors p.3 ISSN: 0040-8166 DESCRIPTION . Tissue and Cell is devoted to original research on the organization of cells, subcellular and extracellular components at all levels, including the grouping and interrelations of cells in tissues and organs. The journal encourages submission of ultrastructural studies that provide novel insights into structure, function and physiology of cells and tissues, in health and disease. Bioengineering and stem cells studies focused on the description of morphological and/or histological data are also welcomed. Studies investigating the effect of compounds and/or substances on structure of cells and tissues are generally outside the scope of this journal. For consideration, studies should contain a clear rationale on the use of (a) given substance(s), have a compelling morphological and structural focus and present novel incremental findings from previous literature. IMPACT FACTOR . 2020: 2.466 © Clarivate Analytics Journal Citation Reports 2021 ABSTRACTING AND INDEXING . Scopus PubMed/Medline Cambridge Scientific Abstracts Current Awareness in Biological Sciences Current Contents - Life Sciences Embase Embase Science Citation Index Web of Science EDITORIAL BOARD . Editor Pietro Lupetti, University of Siena, Siena, Italy AUTHOR INFORMATION PACK 1 Oct 2021 www.elsevier.com/locate/tice 1 Managing Editor Giacomo Spinsanti, University of Siena,
    [Show full text]
  • Newsletternewsletter Volume 1 ■ Number 41 ■ Decemberapril 2003 2003
    newsletternewsletter Volume 1 ■ Number 41 ■ DecemberApril 2003 2003 Welcome In this Issue FEATURES Dear Colleagues, Scholarly Publishing: 12 Observations on the In the transition from the print to the electronic world, technology has Current Situation and Challenges for descended upon the library like a tsunami. Librarians have labored long the Future ..............................................................2-3 and hard to create and be steered by a clear sense of mission in this new age, rather than simply being swept along by the technological wave. Library Vision of the Future: University of Rochester Libraries — There have been enormous challenges in understanding the potential of Geoff Adams the new technology and how to harness it to a needs-driven environment. Focusing on Users, Hiding Technology ............4 Fundamental questions have even been raised about the very value of traditional libraries in this The Future of Librarianship: A View From a new environment, and librarians continue to wrestle with what their future role in the scientific and School of Library and Information Science ......5-6 academic communities will be. Libraries Look to the Future: As a member of these communities Elsevier is equally affected. This highly dynamic environment Place and Space, Physical and Virtual, presents both great challenges and great opportunities. In the course of the last few years we have Where are Libraries Headed? ................................7 seen production, pricing and packaging models from the print journal world change out of all recognition to accommodate the needs of the new digital environment. We have seen the emergence of e-publishing CENTER OF ATTENTION environments such as PUBMED, JSTOR, and most recently the Open Access movement.
    [Show full text]
  • The Rewards of Platform Unity: Moving to One Repository at Universidad De La Salle Delivers Benefits
    Case Study The rewards of platform unity: moving to one repository at Universidad de La Salle delivers benefits To better support the mission that drives Colombia’s Universidad de La Salle — to generate knowledge that will transform Colombian society by contributing to equity, the defense of life and human development — the university recognized the need to combine three separate digital platforms into a single unifying online presence while simultaneously addressing a long list of technical challenges. After considering several options, it identified Digital Commons as the perfect fit for its needs. This case study charts the university’s decision-making process, the rewards it has subsequently reaped and eight tips for other institutions embarking on a digital repository journey. Introduction Founded in 1964, Universidad de La Salle1 is a private Catholic the other its digital educative resources. So, a cross-department institution with around 14,000 students and 700 postgraduates task force set out to find a single solution that would provide enrolled in a wide array of courses and degree programs. It them with key items on their wish list: is rated a “High Quality University” by Colombia’s National Accreditation Council2 (CNA). Back in 2018, the institution’s five • One entry point to the university’s intellectual output journals were stored on Public Knowledge Project’s Open Journal • Support for the full journal-publishing cycle Systems (OJS) platform. Initially, OJS ticked many boxes for the (including peer review) journals team, as Editorial Head Alfredo Morales recalls: “We • Robust customer support were able to consolidate all our titles, standardize publishing criteria and increase visibility inside and outside the university.” • Effective SEO and indexing of journal articles in Google Scholar • Standardization of metadata But the team also encountered issues that impacted their productivity and content discoverability.
    [Show full text]
  • 5455 Wilshire Blvd, #806 . Los Angeles, CA
    September 1, 2016 Erik Engstrom CEO, RELX Group 1-3 Strand London, WC2N 5JR, UK RE: ME/CFS coverage in your publication, The Lancet Dear Mr. Engstrom, On behalf of the Solve ME/CFS Initiative and as a patient with Myalgic encephalomyelitis (ME), commonly known as Chronic Fatigue Syndrome (CFS), I am writing to bring your attention to a matter of vital importance to the ME/CFS community, the PACE Trials and your publication, The Lancet. I am writing to ask that you continue the good name and reputation of The Lancet within the ME/CFS scientific community by facilitating an open discussion of the PACE trials and committing to publish an independent review of the trial data now that a First- Tier Tribunal has ordered the data to be released. As you may know, ME/CFS is a complex, neuro-immune disease with no known cause, treatment, diagnostic tool, nor cure. It is estimated that up to 20 million people worldwide are stricken with ME/CFS from ages 10 to 80 of any race, gender, or socio- economic class and this disease leaves its patients with lower quality of life scores than lung cancer, stroke, and rheumatoid arthritis. (Source: Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness IOM 2015 And, The Health- Related Quality of Life for Patients with Myalgic Encephalomyelitis / Chronic Fatigue Syndrome. PLoS One. 2015; 10(7): e0132421.Published online 2015 Jul 6.) The PACE Trials concluded, in contrast to over 4,000 other scientific publications, that this disease was psychological in nature. The Pace Trial evaluated a series of treatments which it claimed was successful in helping patients with ME/CFS.
    [Show full text]
  • Get Noticed Promoting Your Article for Maximum Impact Get Noticed 2 GET NOTICED
    Get Noticed Promoting your article for maximum impact GET NOTICED 2 GET NOTICED More than one million scientific articles are published each year, and that number is rising. So it’s increasingly important for you to find ways to make your article stand out. While there is much that publishers and editors can do to help, as the paper’s author you are often best placed to explain why your findings are so important or novel. This brochure shows you what Elsevier does and what you can do yourself to ensure that your article gets the attention it deserves. GET NOTICED 3 1 PREPARING YOUR ARTICLE SEO Optimizing your article for search engines – Search Engine Optimization (SEO) – helps to ensure it appears higher in the results returned by search engines such as Google and Google Scholar, Elsevier’s Scirus, IEEE Xplore, Pubmed, and SciPlore.org. This helps you attract more readers, gain higher visibility in the academic community and potentially increase citations. Below are a few SEO guidelines: • Use keywords, especially in the title and abstract. • Add captions with keywords to all photographs, images, graphs and tables. • Add titles or subheadings (with keywords) to the different sections of your article. For more detailed information on how to use SEO, see our guideline: elsevier.com/earlycareer/guides GIVE your researcH THE IMpact it deserVes Thanks to advances in technology, there are many ways to move beyond publishing a flat PDF article and achieve greater impact. You can take advantage of the technologies available on ScienceDirect – Elsevier’s full-text article database – to enhance your article’s value for readers.
    [Show full text]
  • Sciencedirect ® Sciencedirect Books: High Impact, Relevant Content
    ScienceDirect ® ScienceDirect Books: High impact, relevant content These days, a world of information is at our fingertips. Simple online searches return millions of pages that claim to provide expert, timely information. But we’ve all had the experience of wondering if the information is trustworthy, accurate and the best to address our needs. Even casual web searchers are left wondering how to decipher the irrelevant information that fills online search result pages, so what’s a serious researcher to do in a world of overwhelming content and underwhelming relevancy? Elsevier offers greater clarity and insights for researchers by putting their needs first. ScienceDirect: A maximum impact, trusted research solution that delivers ScienceDirect, Elsevier’s leading online full-text information solution, is more than just a research destination for scientists; it’s a continuously evolving, dynamic repository that is constantly updated with the very latest research data available on a variety of subjects. Using the latest technology, the platform provides users with the answers they need, when they need them across a broad range of topics in science, technology and health, helping users attain a greater depth of information than other research solutions provide. Our data driven approach A user focused perspective based on the workflow and understanding the needs of researchers to build our publishing strategy Elsevier offers greater clarity and insights for researchers decisions. By providing data and analysis of their by putting their needs first. A wide range of relevant institution’s usage behavior on ScienceDirect to identify content combined with cutting-edge technology on the content gaps, a clear picture of in-demand content ScienceDirect platform provides quick, easily accessible emerges.
    [Show full text]
  • Information for Authors
    Information for Authors The Lancet is an international general medical journal that will consider any original contribution that advances or illuminates medical science or practice, or that educates or entertains the journal’s readers. Whatever you have written, remember that it is the general reader whom you are trying to reach. One way to find out if you have succeeded is to show your draft to colleagues in other specialties. If they do not understand, neither, very probably, will The Lancet’s staff or readers. Manuscripts must be solely the work of the author(s) stated, must not have been previously published elsewhere, and must not be under consideration by another journal. For randomised controlled trials or research papers judged to warrant fast dissemination, The Lancet will publish a peer-reviewed manuscript within 4 weeks of receipt (see Swift+ and Fast-track publication). If you wish to discuss your proposed fast-track submission with an editor, please call one of the editorial offices in London (+44 [0] 20 7424 4950), New York (+1 212 633 3667), or Beijing (+86 10 852 08872). The Lancet is a signatory journal to the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Recommendations for the Medical Journals, issued by the International Committee of Medical Journal Editors (ICMJE Recommendations), and to the Committee Conduct, Reporting, Editing, on Publication Ethics (COPE) code of conduct for editors. We follow COPE’s guidelines. and Publication of Scholarly Work in Medical Journals http://www.icmje.org If your question is not addressed on these pages then the journal’s editorial staff in London (+44 [0] 20 7424 4950), New York (+1 212 633 3810), or Beijing (+86 10 852 08872) will be pleased to help (email [email protected]).
    [Show full text]
  • Elsevier, Bepress, and a Glimpse at the Future of Scholarly Communication Christine L Ferguson, Murray State University
    Murray State University From the SelectedWorks of Cris Ferguson 2018 Elsevier, bepress, and a Glimpse at the Future of Scholarly Communication Christine L Ferguson, Murray State University Available at: https://works.bepress.com/christine-l-ferguson/45/ Balance Point Elsevier, bepress, and a Glimpse at the Future of Scholarly Communication Cris Ferguson, Column Editor Director of Technical Services, Waterfield Library, Murray State University, Murray, KY 42071; phone: 270-809-5607; email: [email protected]; ORCID: http://orcid.org/0000- 0001-8410-6010 Keywords Elsevier; bepress; open access; Penn Libraries; Digital Commons; scholarly communications Abstract The acquisition of bepress by Elsevier in August 2017, while unpopular among many librarians, provides both companies opportunities for expansion and growth. This Balance Point column outlines some of the benefits to both companies and the reaction by the library community. Also addressed is the announcement by the Penn Libraries that they are searching for a new open source repository potentially to replace bepress’s Digital Commons. The column concludes with some discussion of Elsevier’s relationship with open access content and the impact of the acquisition on the scholarly communications infrastructure. On August 2, 2017, Elsevier announced its acquisition of bepress, the provider of the Digital Commons institutional repository platform. Digital Commons “allows institutions to collect, organize, preserve and disseminate their intellectual output, including preprints, working papers, journals or specific articles, dissertations, theses, conference proceedings and a wide variety of other data” (Elsevier, August 2, 2017). bepress’s other major service, the Experts Gallery Suite, focuses on showcasing the expertise and scholarship of faculty. At the time Elsevier acquired the company, bepress had more than 500 customers using Digital Commons, and over 100 institutions using the Experts Gallery Suite.
    [Show full text]
  • Current Opinion in Chemical Engineering
    CURRENT OPINION IN CHEMICAL ENGINEERING AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Impact Factor p.2 • Abstracting and Indexing p.2 • Editorial Board p.2 • Guide for Authors p.4 ISSN: 2211-3398 DESCRIPTION . Current Opinion in Chemical Engineering is devoted to bringing forth short and focused review articles written by experts on current advances in different areas of chemical engineering. Only invited review articles will be published. The goals of each review article in Current Opinion in Chemical Engineering are: 1. To acquaint the reader/researcher with the most important recent papers in the given topic. 2. To provide the reader with the views/opinions of the expert in each topic. The reviews are short (about 2500 words or 5-10 printed pages with figures) and serve as an invaluable source of information for researchers, teachers, professionals and students. The reviews also aim to stimulate exchange of ideas among experts. Themed sections: Each review will focus on particular aspects of one of the following themed sections of chemical engineering: 1. Nanotechnology 2. Energy and environmental engineering 3. Biotechnology and bioprocess engineering 4. Biological engineering (covering tissue engineering, regenerative medicine, drug delivery) 5. Separation engineering (covering membrane technologies, adsorbents, desalination, distillation etc.) 6. Materials engineering (covering biomaterials, inorganic especially ceramic materials, nanostructured materials). 7. Process systems engineering 8. Reaction engineering and catalysis. Selection of the topics to be reviewed: Section Editors of each themed section are authorities in the field and are selected by the Editors of the journal. They divide their section into a number of topics ensuring that the field is comprehensively covered and that all issues of current importance are emphasized.
    [Show full text]
  • CAGEO Gfa April2010.Pdf
    Guide for Authors – Computers & Geosciences It can be advantageous to print this "Guide for Authors" section for reference during the subsequent stages of article preparation. Summary of Important Items when submitting a manuscript 1) Be certain that your manuscript contains suitable material for the journal (computing methods in the physical geosciences). Out of scope articles will be returned to authors without review. Please read the Aims & Scope of the journal. 2) Please read the Elsevier web page on Publishing Ethics: www.elsevier.com/publishingethicskit. 3) Please provide a covering letter explaining the contribution of the manuscript. 4) Grammar, spelling and accuracy are considered as the most important screening criterion. If your manuscript contains errors in English, it will be returned. Non- English speaking authors are encouraged to have their manuscript checked and edited by a native English speaker. Alternatively, the use of language editing services can be used to improve the English of a manuscript. 5) Manuscripts, which do not meet the novelty, significance, and competence criteria (Aims & Scope of the journal) will be returned to authors at any stage, at the discretion of the Editor. 6) References must follow the format as stipulated in this guide. Your manuscript will be returned if the format of the references is not correct. 7) Ensure that figures are adequately labelled (coordinates, scale bar, orientation) and the resolution is sufficient for publication scale. 8) Choose the appropriate article type (Research, Application, Review or Short Note articles – see Aims & Scope). Ensure your manuscript falls within the word limit for the article type that you choose.
    [Show full text]
  • Annual Reports and Financial Statements 2014 Statements Financial and Reports Annual
    Annual Reports and Financial Statements 2014 Annual Reports and Financial Statements www.relxgroup.com 2014 21654 Reed AR 2014 Cover Outer and Inner.indd 1-3 05/03/2015 18:52 RELX Group is a world-leading provider of information solutions for professional customers Credits across industries. Designed and produced by We help scientists make new discoveries, lawyers mslgroup.com Board photography by win cases, doctors save lives, and executives forge Douglas Fry, Piranha Photography Printed by commercial relationships with their clients. We help Pureprint Group, ISO14001, FSC® certified and CarbonNeutral® The 2014 Annual Reports and Financial Statements is printed insurance groups offer customers lower prices using paper containing a minimum of 75% recycled content, of which 100% is de-inked post-consumer waste. All of the pulp by assessing risk better, and save taxpayers and is bleached using an elemental chlorine free process (ECF). Printed in the UK by Pureprint using their environmental printing technology; vegetable inks were used throughout. Pureprint is a consumers money by enabling governments and CarbonNeutral® company. Both manufacturing mill and printer are ISO14001 registered and are Forest Stewardship Council® financial groups to detect fraud. (FSC) chain-of-custody certified. RELX Group is owned by two parent companies: Reed Elsevier PLC is the London Stock Exchange listed vehicle for holding shares in RELX Group. Shareholders in Reed Elsevier PLC own a 52.9% economic interest in the Group. Reed Elsevier NV is the Amsterdam Stock Exchange listed vehicle for holding shares in RELX Group. External shareholders in Reed Elsevier NV own a 47.1% economic interest in the Group.
    [Show full text]
  • This Article Appeared in a Journal Published by Elsevier. the Attached
    This article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and education use, including for instruction at the authors institution and sharing with colleagues. Other uses, including reproduction and distribution, or selling or licensing copies, or posting to personal, institutional or third party websites are prohibited. In most cases authors are permitted to post their version of the article (e.g. in Word or Tex form) to their personal website or institutional repository. Authors requiring further information regarding Elsevier’s archiving and manuscript policies are encouraged to visit: http://www.elsevier.com/copyright Author's personal copy Available online at www.sciencedirect.com The Social Science Journal 47 (2010) 802–818 Employment discrimination in upscale restaurants: Evidence from matched pair testing Marc Bendick Jr. a,∗, Rekha Eanni Rodriguez b,1, Sarumathi Jayaraman c,d,2 a Bendick and Egan Economic Consultants, Inc.,Washington, DC, USA b Restaurant Opportunities Center of New York, New York, NY, USA c Political Science Department, Brooklyn College, Brooklyn, NY, USA d Restaurant Opportunity Center-United, New York, NY, USA Received 3 February 2009; received in revised form 11 March 2010; accepted 5 April 2010 Abstract White and racial minorities with equal qualifications applied simultaneously for 43 waiter/waitress jobs in New York City fine dining restaurants. Applicants of all demographic backgrounds were treated with equal courtesy, but minorities were only 54% as likely as whites to receive a job offer. This discrimination, either conscious or unconscious, was documented in 31% of restaurants tested.
    [Show full text]